Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 1997

View Archived Issues

Initial phase III results announced for pramlintide

CardioSynopsis, IHIM to co-develop novel stents

IND filed by Dusa for Levulan photodetection

Positive phase III results for Lidakol in oral herpes

Chiron Diagnostics launches breast cancer test

Alaris enters marketing agreement with Luther Medical

Three patents issued for ProLease and Medisorb

Alkermes and Janssen sign supply agreement

Generic Cardizem CD open for FDA review

Preclinical results on AVI-2221 for restenosis

Penederm launches Avita acne cream

Infanrix Hep B approved in all EU countries

ETA/ETB antagonist protects against renal insufficiency in canine model

Novopharm Biotech antibodies poised to enter phase I

Optison evaluated in phase II trials for myocardial perfusion imaging

Trega Biosciences refocuses development of HP-228

Analgesic mGluR antagonists reported in patent literature

Novel immunotoxins for the treatment of AIDS

Clobenpropit shows memory-enhancing activity in preclinical models

Tachykinin antagonist with potential as antiasthmatic

Efficacy of long-term treatment with dronabinol for AIDS-related anorexia

Antidepressant activity described for 5-HT reuptake inhibitor/5-HT antagonist

Bristol-Myers Squibb describes new taxanes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...